The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the Pharmaceuticals, Biotechnology and Generics sectors of the overall health care industry, backed by a team of respected writers with many years of experience in the field.
Bayer’s 2nd-qtr 2010 profits dip 1.3% on charges and write down, despite 14.6% revenue hike
30 July 2010
Germany’s Bayer AG saw second-quarter net earnings slip 1.3% to 525 million euros ($672.9 million),
Latest Pharma Letter Articles
Merck KGaA sees 2nd-qtr 2010 profits rocket around 70%, with revenues rising 15.6%
30 July 2010
German drugs and liquid crystals marker Merck KGaA posted a spectacular set of second-quarter
Think tank calls for US FDA to forgo approval of drugs cleared by European regulator
30 July 2010
A new report from the US free-market think tank Pacific Research Institute argues that American
Uptake of alternative biologics such as Roche/Chugai's Actemra/RoActemra will erode RA market share of TNF-alpha inhibitors through 2019
30 July 2010
In the rheumatoid arthritis (RA) drug market, the uptake of alternative biologics such as Roche/Chugai's
India’s DCGI sets stringent rules for clinical trials
28 July 2010
India’s pharmaceutical regulator, the Drugs Controller General of India (DCGI), has tightened
US generic group GPhA slams FTC position on patent settlements as “misguided”
29 July 2010
Commenting on US Federal Trade Commission Chairman Jon Leibowitz’ testimony before the House
Hovione's sales grow 15% for FY to March 2010
29 July 2010
Portuguese drugmaker Hovione announced yesterday that the consolidated sales for the fiscal
Latest Events
Pharma CI Conference 2010
10th Annual Biotech in Europe Investor Forum
News From the Web
Lowest Relative Performance in the Biotechnology Industry Detected in Shares ...
30 July 2010 | Comtex Smartrend
Glenmark launches pain relief drug in US
30 July 2010 | Hindu Business Line
Fuji Pharmaceutical <4554.Q>-2009/10 div forecast
30 July 2010 | Reuters
Curaxis Pharmaceutical Corp. Announces Completion of Reverse Merger With Auto ...
29 July 2010 | MarketWatch (press release)
Amgen 2Q net income slips on higher taxes
29 July 2010 | The Associated Press
Acura Pharmaceuticals Reports Second Quarter 2010 Financial Results
29 July 2010 | MarketWatch (press release)
PPD Expands cGMP Laboratory Services in North America
29 July 2010 | MarketWatch (press release)
Meeting rejects Biotechnology Bill
29 July 2010 | The Hindu
Covidien Q3 profit beats Street, but pharma weak
29 July 2010 | Reuters
Interim Report of BB BIOTECH AG as of June 30, 2010
29 July 2010 | MarketWatch
Allos Therapeutics 2Q loss widens on costs
29 July 2010 | BusinessWeek
- AstraZeneca files patent suit against Indian partner Torrent over blockbuster cholesterol drug Crestor; Eli Lilly loses Gemzar patent appeal
- US FDA advisory panel backs AstraZeneca’s Brilinta, as firm posts 22% rise in core EPS for 2nd-qtr 2010
- UK patients less likely than other Europeans to receive innovative drugs for cancer and chronic diseases, DoH study finds
- Sanofi-Aventis 2nd-qtr 2010 earnings up 8%, but firm still mute on Genzyme acquisition; sues over Lovenox
- India’s DCGI sets stringent rules for clinical trials
